Mycoplasma genitalium (Mgen) is a recognised sexually transmitted infection (STI) with clinical presentation similar to that of Chlamydia trachomatis (CT).
Key facts:
- M. genitalium is a leading cause of non-gonococcal urethritis in men (NGU)1. In women, it has been associated with Pelvic Inflammatory Disease (PID), which can lead to tubal factor infertility, ectopic pregnancy, and chronic pelvis pain2.
- Prevalence of Mgen can range from 1% – 4% in the general population and in higher risk populations can range from 9% – >50%, often exceeding that of Neisseria gonorrhoeae (NG) 3.
- Prevalence of Mgen in less developed countries can be 3 times higher than in developed territories3.
- Screening for Mgen using NAATs could lead to significant reductions in rates of PID in women due to Mgen, with cumulative incidence over 20 years reduced by 31.1%4.
Benefits of CT Mycoplasma genitalium:
- Highly sensitive assay
- Validated male and female urine and vaginal swabs
- No repeat testing – LAMP technology is characteristically tolerant of potentially inhibitory sample
- In combination with HG CT/NG Combo, one single urine or swab sample can test for three of the most common STIs – C. trachomatis (CT), N. gonorrhoeae (NG) and M. genitalium (Mgen)
Test information
Methodology: | Loop Mediated Isothermal Amplification (LAMP) |
Target: | Mycoplasma genitalium |
Sample types: | Urine and vaginal swabs |
Hands-on time: | 5 minutes |
Sample to result: | 66 minutes |
Ordering Information
Product Name | # of Tests | Catalogue |
HG MYG | 30 | HGMYGR |
HG MYG Control | 18 | HGMYGC |
HG Swift | – | HGSWIFT |
Mini Heating Dry Bath Incubator | – | HGHEATB |
Mini Centrifuge | – | HGCFUGE |
Mini Vortex | – | HGVORTEX |
References
- PJ. Horner and DH. Martin,The Journal of Infectious Diseases, vol. 216, pp. 396-405, 2017.
- HC. Wiesenfeld, and LE. Manhart. The Journal of Infectious Diseases, vol. 216, pp. 389-395, 2017
- Baumann L, et al. Sex Transm Infect 2018;94:254–261
- Birger, et al. Scientific Reports 7, 16162 (2017).